Can a simple blood test predict skin cancer outcomes?
NCT ID NCT06608511
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at blood samples from 20 adults with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long someone lives. Researchers will compare these markers to standard measures like tumor response and survival. The goal is to find better ways to monitor the disease without relying only on scans or biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA OF SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up hidden cancers?
- Can a tiny biopsy outsmart skin Cancer's spread?
- Can your genes predict your melanoma risk?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Which High-Tech camera is better at spotting skin cancer?
- A UV photo and a cheek swab may be the keys to stopping sunburn before it starts